33
/fr/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512564
319423
2
Public Timelines
FAQ Obtenir le Premium

1 janv. 2014 - Pembrolizumab

Description:

Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.

Ajouté au bande de temps:

14 nov. 2019
0
0
302

Date:

1 janv. 2014
Maintenaint
~ Il y a 11 ans